Modulation of cisplatin pharmacodynamics by Cremophor EL
- 1 January 2002
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (1) , 205-213
- https://doi.org/10.1016/s0959-8049(01)00348-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- In vitro antagonistic cytotoxic interactions between platinum drugs and taxanes on bone marrow progenitor cell CFU-GMAnti-Cancer Drugs, 1999
- Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and CarboplatinJournal of Clinical Oncology, 1999
- Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor ELPublished by Elsevier ,1997
- 1108: Phase I study of weekly clsplatln (P) and weekly or four weekly taxol (T) in patients with advanced ovarian cancerEuropean Journal Of Cancer, 1997
- A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 1997
- Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neckEuropean Journal Of Cancer, 1997
- Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumorsAnnals of Oncology, 1995
- Weekly high-dose cisplatin in malignant pleural mesotheliomaAnnals of Oncology, 1994
- Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumoursBritish Journal of Cancer, 1993
- Sequences of taxol and cisplatin: a phase I and pharmacologic study.Journal of Clinical Oncology, 1991